Key result
Higher serum indoxyl sulfate is linked to reduced endothelial function in stages 3-5 CKD.
Why the study?
Indoxyl sulfate is negatively correlated with renal function and cardiovascular diseases in CKD, prompting investigation into its association with endothelial function.
Is serum indoxyl sulfate level associated with endothelial function in patients with stages 3-5 chronic kidney disease?
Cross-Sectional (n=110)
Is serum indoxyl sulfate level associated with endothelial function in patients with stages 3-5 chronic kidney disease?
Higher serum indoxyl sulfate levels are independently associated with worse endothelial function in patients with stages 3-5 chronic kidney disease.
Hypothesis-generating for indoxyl sulfate in CKD endothelial dysfunction; prospective studies needed before clinical consideration.
Indoxyl sulfate (IS), a product metabolized from tryptophan, is negatively correlated with renal function and cardiovascular diseases in patients with chronic kidney disease (CKD). We investigated the association between serum IS levels and endothelial function in patients with CKD. Fasting blood samples were obtained from 110 patients with stages 3-5 CKD. The endothelial function, represented by vascular reactivity index (VRI), was measured non-invasively using digital thermal monitoring. Serum IS levels were determined using liquid chromatography-mass spectrometry. Twenty-one (19.1%), 36 (32.7%), and 53 (48.2%) patients had poor (VRI < 1.0), intermediate (1.0 ≤ VRI < 2.0), and good (VRI ≥ 2.0) vascular reactivity. By univariate linear regression analysis, a higher prevalence of smoking, advanced age, higher systolic, and diastolic blood pressure (DBP), elevated levels of serum phosphorus, blood urea nitrogen, creatinine, and IS were negatively correlated with VRI values, but estimated glomerular filtration rate negatively associated with VRI values. After being adjusted by using multivariate stepwise linear regression analysis, DBP and IS levels were significantly negatively associated with VRI values in CKD patients. We concluded that IS level associated inversely with VRI values and had a modulating role in endothelial function in patients with stages 3-5 CKD.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) conducted a cross-sectional in Stages 3-5 chronic kidney disease (n=110). Serum indoxyl sulfate levels was evaluated on Endothelial function (vascular reactivity index). Higher serum indoxyl sulfate levels were significantly negatively associated with vascular reactivity index values, indicating a modulating role in endothelial function in stages 3-5 CKD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: